这种成分是什么?

이 원료는 다음의 구조를 갖는 2-에틸헥산올과 메타크릴릭애씨드의 에스터이다.

成分词典

ETHYLHEXYL METHACRYLATE

美国FDA 物质登记 · UNII 8Q7XLQ325N · 登记名称 2-ETHYLHEXYL METHACRYLATE · 单一化学物质

在涂抹处形成薄膜FILM FORMING

未列入韩国有毒物质 GHS 分类 · 现有化学物质

Other restriction: ban substances that deplete the ozone layer

详细资料——标示名称、识别编号、物性、试验记录、文献

日本化妆品工业联合会标示名称メタクリル酸エチルヘキシル: 本品は、メタクリル酸と２－エチルヘキサノールのエステルであり、次の化学式で表される。

ETHYLHEXYL METHACRYLATEINCI에틸헥실메타크릴레이트韩国标示名称（食药处标准名）2-Propenoic acid, 2-methyl-, 2-ethylhexyl ester同义名メタクリル酸エチルヘキシル日本标示名称

性状: Liquid, CBI · Liquid, [ICSC] Colorless liquid with an odor of ether, [MSDSonline]
沸点: 110 °C @ 14 mm Hg · 113-224 °C
溶解性: Solubility in water: none
密度: 0.880 g/cu cm @ 25 °C · Relative density (water = 1): 0.9
稳定性: Storage of this product at elevated temperatures (>30 °C or >85 °F) reduces the shelf-life. The typical shelf-life for this product is 12 months. /Formulation >99% 2-ethylhexyl methacrylate/
初沸点和沸程: 113~224 ℃
闪点: 92 ℃
蒸气压: 133 ㎩ (20℃)
溶解度: 0.000592 g/100㎖ (25℃ (估算值))
蒸气密度: 6.8
比重: 0.9
正辛醇/水分配系数（Kow）: 4.54
分子量: 198.3

这是对物质本身测得的数值。韩国安全保健公团（KOSHA）的资料仅供编写和审核安全数据表参考，并非原料商品的规格。

这是向美国 EPA 申报含该成分的 8 款产品的用途。其中包括化妆品以外的产品，排在前几行的即为该成分的主要用途。

记录有皮肤试验 6 项、眼部试验 3 项。

归类为刺激性高1 项归类为中等3 项归类为低1 项

各项试验结论不一（最多的结论占 20%），因此不能断定该成分有刺激性。这是对原料本身的试验记录，与成品中所含浓度下的刺激性不同。

查看全部 9 项试验

Moderate or Mild Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act Regulations, Section 191.12, Federal Register: 29, 13009 (1964) according to
Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) individual approach (adopted 22 July 2010) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) (dated May 30, 2008)
Category 2
Skin Irritation · Screening
Classification not possible
Skin Sensitization · Screening
Moderate or Mild Irritation
skin irritation: in vivo · Screening · other guideline: "Appraisal of the safety of chemicals in foods, drugs and cosmetics", Division of Pharmacology, FDA (Draize) (1959). according to
High Frequency of Sensitization
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
Not classified
Eye Irritation · Screening
Moderate or Mild Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act Regulations, Section 191.12, Federal Register: 29, 13009 (1964) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: "Appraisal of the safety of chemicals in foods, drugs and cosmetics", Division of Pharmacology, FDA (Draize) (1959) according to